Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 512 entries
Sorted by: Best Match Show Resources per page
[Discussion: on studies of clinical nursing - a theoretical image and the true status].

Kango kenkyu. The Japanese journal of nursing research

Ujiie S, Takahashi R, Hattori H, Fujisawa Y, Sugimori K.
PMID: 253805
Kango Kenkyu. 1979;12(2):123-34.

No abstract available.

Cite
Ujiie S, Takahashi R, Hattori H, et al. [Discussion: on studies of clinical nursing - a theoretical image and the true status]. Kango Kenkyu. 1979;12(2):123-34
Ujiie, S., Takahashi, R., Hattori, H., Fujisawa, Y., & Sugimori, K. (1979). [Discussion: on studies of clinical nursing - a theoretical image and the true status]. Kango kenkyu. The Japanese journal of nursing research, 12(2), 123-34.
Ujiie, S, et al. "[Discussion: on studies of clinical nursing - a theoretical image and the true status]." Kango kenkyu. The Japanese journal of nursing research vol. 12,2 (1979): 123-34.
Ujiie S, Takahashi R, Hattori H, Fujisawa Y, Sugimori K. [Discussion: on studies of clinical nursing - a theoretical image and the true status]. Kango Kenkyu. 1979;12(2):123-34. Japanese. PMID: 253805.
Copy Download .nbib Format: NLM
Rationale and design of ASSAF-K (A study of the safety and efficacy of anticoagulant therapy in the treatment of atrial fibrillation in Kanagawa).

Journal of arrhythmia

Hatori Y, Sakai H, Kunishima T, Hatori N, Chen L, Ishigami T, Satoh N.
PMID: 28416976
J Arrhythm. 2017 Apr;33(2):111-116. doi: 10.1016/j.joa.2016.07.008. Epub 2016 Aug 23.

BACKGROUND: Atrial fibrillation (AF) is one of the most prevalent cardiac arrhythmias associated with substantially increased risks of ischemic stroke and thromboembolism. Oral anticoagulants (OACs) are the cornerstone of AF management and effectively prevent AF-related stroke. As new non-vitamin...

Cite
Hatori Y, Sakai H, Kunishima T, et al. Rationale and design of ASSAF-K (A study of the safety and efficacy of anticoagulant therapy in the treatment of atrial fibrillation in Kanagawa). J Arrhythm. 2016;33(2):111-116doi: 10.1016/j.joa.2016.07.008.
Hatori, Y., Sakai, H., Kunishima, T., Hatori, N., Chen, L., Ishigami, T., Satoh, N. (2017). Rationale and design of ASSAF-K (A study of the safety and efficacy of anticoagulant therapy in the treatment of atrial fibrillation in Kanagawa). Journal of arrhythmia, 33(2), 111-116. https://doi.org/10.1016/j.joa.2016.07.008
Hatori, Yutaka, et al. "Rationale and design of ASSAF-K (A study of the safety and efficacy of anticoagulant therapy in the treatment of atrial fibrillation in Kanagawa)." Journal of arrhythmia vol. 33,2 (2017): 111-116. doi: https://doi.org/10.1016/j.joa.2016.07.008
Hatori Y, Sakai H, Kunishima T, Hatori N, Chen L, Ishigami T, Satoh N. Rationale and design of ASSAF-K (A study of the safety and efficacy of anticoagulant therapy in the treatment of atrial fibrillation in Kanagawa). J Arrhythm. 2017 Apr;33(2):111-116. doi: 10.1016/j.joa.2016.07.008. Epub 2016 Aug 23. PMID: 28416976; PMCID: PMC5388051.
Copy Download .nbib Format: NLM
Feasibility of improving platelet-rich plasma therapy by using chitosan with high platelet activation ability.

Experimental and therapeutic medicine

Hattori H, Ishihara M.
PMID: 28450960
Exp Ther Med. 2017 Mar;13(3):1176-1180. doi: 10.3892/etm.2017.4041. Epub 2017 Jan 13.

Platelet-rich plasma (PRP) is blood plasma containing a high number of platelets that release growth factors for wound healing and tissue regeneration. In the present study, the feasibility of improving PRP therapy by using chitosan that exhibits high platelet...

Cite
Hattori H, Ishihara M. Feasibility of improving platelet-rich plasma therapy by using chitosan with high platelet activation ability. Exp Ther Med. 2017;13(3):1176-1180doi: 10.3892/etm.2017.4041.
Hattori, H., & Ishihara, M. (2017). Feasibility of improving platelet-rich plasma therapy by using chitosan with high platelet activation ability. Experimental and therapeutic medicine, 13(3), 1176-1180. https://doi.org/10.3892/etm.2017.4041
Hattori, Hidemi, and Ishihara, Masayuki. "Feasibility of improving platelet-rich plasma therapy by using chitosan with high platelet activation ability." Experimental and therapeutic medicine vol. 13,3 (2017): 1176-1180. doi: https://doi.org/10.3892/etm.2017.4041
Hattori H, Ishihara M. Feasibility of improving platelet-rich plasma therapy by using chitosan with high platelet activation ability. Exp Ther Med. 2017 Mar;13(3):1176-1180. doi: 10.3892/etm.2017.4041. Epub 2017 Jan 13. PMID: 28450960; PMCID: PMC5403699.
Copy Download .nbib Format: NLM
Pitavastatin subacutely improves endothelial function and reduces inflammatory cytokines and chemokines in patients with hypercholesterolaemia.

Heart Asia

Takase B, Hattori H, Tanaka Y, Nagata M, Ishihara M.
PMID: 27326130
Heart Asia. 2013 Sep 13;5(1):204-9. doi: 10.1136/heartasia-2013-010368. eCollection 2013.

BACKGROUND: Pitavastatin is a statin with strong pleiotropic effects, but the effects of pitavastatin on endothelial cell function (ECF) and both inflammatory cytokines and chemokines have not been fully investigated.MATERIAL AND METHODS: We simultaneously measured brachial artery (BA) flow-mediated...

Cite
Takase B, Hattori H, Tanaka Y, et al. Pitavastatin subacutely improves endothelial function and reduces inflammatory cytokines and chemokines in patients with hypercholesterolaemia. Heart Asia. 2013;5(1):204-9doi: 10.1136/heartasia-2013-010368.
Takase, B., Hattori, H., Tanaka, Y., Nagata, M., & Ishihara, M. (2013). Pitavastatin subacutely improves endothelial function and reduces inflammatory cytokines and chemokines in patients with hypercholesterolaemia. Heart Asia, 5(1), 204-9. https://doi.org/10.1136/heartasia-2013-010368
Takase, Bonpei, et al. "Pitavastatin subacutely improves endothelial function and reduces inflammatory cytokines and chemokines in patients with hypercholesterolaemia." Heart Asia vol. 5,1 (2013): 204-9. doi: https://doi.org/10.1136/heartasia-2013-010368
Takase B, Hattori H, Tanaka Y, Nagata M, Ishihara M. Pitavastatin subacutely improves endothelial function and reduces inflammatory cytokines and chemokines in patients with hypercholesterolaemia. Heart Asia. 2013 Sep 13;5(1):204-9. doi: 10.1136/heartasia-2013-010368. eCollection 2013. PMID: 27326130; PMCID: PMC4832709.
Copy Download .nbib Format: NLM
A novel C-terminal truncating .

Human genome variation

Hattori A, Zukeran H, Igarashi M, Toguchi S, Toubaru Y, Inoue T, Katoh-Fukui Y, Fukami M.
PMID: 28326187
Hum Genome Var. 2017 Mar 16;4:17008. doi: 10.1038/hgv.2017.8. eCollection 2017.

Nuclear receptor subfamily 5, group A, member 1 (NR5A1) is a nuclear receptor involved in gonadal and adrenal development. We identified a novel C-terminally truncating

Cite
Hattori A, Zukeran H, Igarashi M, et al. A novel C-terminal truncating . Hum Genome Var. 2017;4:17008doi: 10.1038/hgv.2017.8.
Hattori, A., Zukeran, H., Igarashi, M., Toguchi, S., Toubaru, Y., Inoue, T., Katoh-Fukui, Y., & Fukami, M. (2017). A novel C-terminal truncating . Human genome variation, 417008. https://doi.org/10.1038/hgv.2017.8
Hattori, Atsushi, et al. "A novel C-terminal truncating ." Human genome variation vol. 4 (2017): 17008. doi: https://doi.org/10.1038/hgv.2017.8
Hattori A, Zukeran H, Igarashi M, Toguchi S, Toubaru Y, Inoue T, Katoh-Fukui Y, Fukami M. A novel C-terminal truncating . Hum Genome Var. 2017 Mar 16;4:17008. doi: 10.1038/hgv.2017.8. eCollection 2017. PMID: 28326187; PMCID: PMC5352671.
Copy Download .nbib Format: NLM
Management of Pulmonary Thromboembolism Based on Severity and Vulnerability to Thrombolysis.

Annals of vascular diseases

Fukuda W, Taniguchi S, Fukuda I, Chiyoya M, Aoki C, Kondo N, Hattori K, Daitoku K, Kowatari R, Minakawa M, Suzuki Y.
PMID: 29515698
Ann Vasc Dis. 2017 Dec 25;10(4):371-377. doi: 10.3400/avd.oa.17-00105.

No abstract available.

Cite
Fukuda W, Taniguchi S, Fukuda I, et al. Management of Pulmonary Thromboembolism Based on Severity and Vulnerability to Thrombolysis. Ann Vasc Dis. 2017;10(4):371-377doi: 10.3400/avd.oa.17-00105.
Fukuda, W., Taniguchi, S., Fukuda, I., Chiyoya, M., Aoki, C., Kondo, N., Hattori, K., Daitoku, K., Kowatari, R., Minakawa, M., & Suzuki, Y. (2017). Management of Pulmonary Thromboembolism Based on Severity and Vulnerability to Thrombolysis. Annals of vascular diseases, 10(4), 371-377. https://doi.org/10.3400/avd.oa.17-00105
Fukuda, Wakako, et al. "Management of Pulmonary Thromboembolism Based on Severity and Vulnerability to Thrombolysis." Annals of vascular diseases vol. 10,4 (2017): 371-377. doi: https://doi.org/10.3400/avd.oa.17-00105
Fukuda W, Taniguchi S, Fukuda I, Chiyoya M, Aoki C, Kondo N, Hattori K, Daitoku K, Kowatari R, Minakawa M, Suzuki Y. Management of Pulmonary Thromboembolism Based on Severity and Vulnerability to Thrombolysis. Ann Vasc Dis. 2017 Dec 25;10(4):371-377. doi: 10.3400/avd.oa.17-00105. PMID: 29515698; PMCID: PMC5835442.
Copy Download .nbib Format: NLM
Wheezing and dyspnoea caused by aberrant left innominate artery.

Respirology case reports

Hayashi M, Imaizumi K, Hattori H, Toyama H, Okazawa M.
PMID: 29026607
Respirol Case Rep. 2017 Oct 05;5(6):e00273. doi: 10.1002/rcr2.273. eCollection 2017 Nov.

We present a rare case of a branching anomaly of the aortic arch that resulted in wheezing and dyspnoea. The patient was a 60-year-old male with severe wheezing from babyhood, originally diagnosed with severe bronchial asthma. On auscultation, the...

Cite
Hayashi M, Imaizumi K, Hattori H, et al. Wheezing and dyspnoea caused by aberrant left innominate artery. Respirol Case Rep. 2017;5(6):e00273doi: 10.1002/rcr2.273.
Hayashi, M., Imaizumi, K., Hattori, H., Toyama, H., & Okazawa, M. (2017). Wheezing and dyspnoea caused by aberrant left innominate artery. Respirology case reports, 5(6), e00273. https://doi.org/10.1002/rcr2.273
Hayashi, Masamichi, et al. "Wheezing and dyspnoea caused by aberrant left innominate artery." Respirology case reports vol. 5,6 (2017): e00273. doi: https://doi.org/10.1002/rcr2.273
Hayashi M, Imaizumi K, Hattori H, Toyama H, Okazawa M. Wheezing and dyspnoea caused by aberrant left innominate artery. Respirol Case Rep. 2017 Oct 05;5(6):e00273. doi: 10.1002/rcr2.273. eCollection 2017 Nov. PMID: 29026607; PMCID: PMC5628629.
Copy Download .nbib Format: NLM
Recurrent Fracture After Anterior Tension Band Plating With Bilateral Tibial Stress Fracture in a Basketball Player: A Case Report.

Orthopaedic journal of sports medicine

Hattori H, Ito T.
PMID: 26535378
Orthop J Sports Med. 2015 Oct 12;3(10):2325967115610069. doi: 10.1177/2325967115610069. eCollection 2015 Oct.

No abstract available.

Cite
Hattori H, Ito T. Recurrent Fracture After Anterior Tension Band Plating With Bilateral Tibial Stress Fracture in a Basketball Player: A Case Report. Orthop J Sports Med. 2015;3(10):2325967115610069doi: 10.1177/2325967115610069.
Hattori, H., & Ito, T. (2015). Recurrent Fracture After Anterior Tension Band Plating With Bilateral Tibial Stress Fracture in a Basketball Player: A Case Report. Orthopaedic journal of sports medicine, 3(10), 2325967115610069. https://doi.org/10.1177/2325967115610069
Hattori, Hiroyuki, and Ito, Toshiyuki. "Recurrent Fracture After Anterior Tension Band Plating With Bilateral Tibial Stress Fracture in a Basketball Player: A Case Report." Orthopaedic journal of sports medicine vol. 3,10 (2015): 2325967115610069. doi: https://doi.org/10.1177/2325967115610069
Hattori H, Ito T. Recurrent Fracture After Anterior Tension Band Plating With Bilateral Tibial Stress Fracture in a Basketball Player: A Case Report. Orthop J Sports Med. 2015 Oct 12;3(10):2325967115610069. doi: 10.1177/2325967115610069. eCollection 2015 Oct. PMID: 26535378; PMCID: PMC4622293.
Copy Download .nbib Format: NLM
PET brain kinetics studies of (11)C-ITMM and (11)C-ITDM,radioprobes for metabotropic glutamate receptor type 1, in a nonhuman primate.

American journal of nuclear medicine and molecular imaging

Yamasaki T, Maeda J, Fujinaga M, Nagai Y, Hatori A, Yui J, Xie L, Nengaki N, Zhang MR.
PMID: 24795840
Am J Nucl Med Mol Imaging. 2014 Apr 25;4(3):260-9. eCollection 2014.

The metabotropic glutamate receptor type 1 (mGluR1) is a novel target protein for the development of new drugs against central nervous system disorders. Recently, we have developed (11)C-labeled PET probes (11)C-ITMM and (11)C-ITDM, which demonstrate similar profiles, for imaging...

Cite
Yamasaki T, Maeda J, Fujinaga M, et al. PET brain kinetics studies of (11)C-ITMM and (11)C-ITDM,radioprobes for metabotropic glutamate receptor type 1, in a nonhuman primate. Am J Nucl Med Mol Imaging. 2014;4(3):260-9
Yamasaki, T., Maeda, J., Fujinaga, M., Nagai, Y., Hatori, A., Yui, J., Xie, L., Nengaki, N., & Zhang, M. R. (2014). PET brain kinetics studies of (11)C-ITMM and (11)C-ITDM,radioprobes for metabotropic glutamate receptor type 1, in a nonhuman primate. American journal of nuclear medicine and molecular imaging, 4(3), 260-9.
Yamasaki, Tomoteru, et al. "PET brain kinetics studies of (11)C-ITMM and (11)C-ITDM,radioprobes for metabotropic glutamate receptor type 1, in a nonhuman primate." American journal of nuclear medicine and molecular imaging vol. 4,3 (2014): 260-9.
Yamasaki T, Maeda J, Fujinaga M, Nagai Y, Hatori A, Yui J, Xie L, Nengaki N, Zhang MR. PET brain kinetics studies of (11)C-ITMM and (11)C-ITDM,radioprobes for metabotropic glutamate receptor type 1, in a nonhuman primate. Am J Nucl Med Mol Imaging. 2014 Apr 25;4(3):260-9. eCollection 2014. PMID: 24795840; PMCID: PMC3999406.
Copy Download .nbib Format: NLM
Growth and Endocrine Function in Long-term Adult Survivors of Childhood Stem Cell Transplant.

Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology

Ishiguro H, Yasuda Y, Hyodo H, Tomita Y, Koike T, Shinagawa T, Shimizu T, Morimoto T, Hattori K, Matsumoto M, Inoue H, Yabe H, Yabe M, Shinohara O, Kato S.
PMID: 24790374
Clin Pediatr Endocrinol. 2009;18(1):1-14. doi: 10.1297/cpe.18.1. Epub 2009 Feb 19.

The number of long-term surviving stem cell transplant (SCT) recipients has increased steadily, and attention has now extended to the late complications of this procedure. The objective of this study was to investigate relationship among growth and endocrine functions...

Cite
Ishiguro H, Yasuda Y, Hyodo H, et al. Growth and Endocrine Function in Long-term Adult Survivors of Childhood Stem Cell Transplant. Clin Pediatr Endocrinol. 2009;18(1):1-14doi: 10.1297/cpe.18.1.
Ishiguro, H., Yasuda, Y., Hyodo, H., Tomita, Y., Koike, T., Shinagawa, T., Shimizu, T., Morimoto, T., Hattori, K., Matsumoto, M., Inoue, H., Yabe, H., Yabe, M., Shinohara, O., & Kato, S. (2009). Growth and Endocrine Function in Long-term Adult Survivors of Childhood Stem Cell Transplant. Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology, 18(1), 1-14. https://doi.org/10.1297/cpe.18.1
Ishiguro, Hiroyuki, et al. "Growth and Endocrine Function in Long-term Adult Survivors of Childhood Stem Cell Transplant." Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology vol. 18,1 (2009): 1-14. doi: https://doi.org/10.1297/cpe.18.1
Ishiguro H, Yasuda Y, Hyodo H, Tomita Y, Koike T, Shinagawa T, Shimizu T, Morimoto T, Hattori K, Matsumoto M, Inoue H, Yabe H, Yabe M, Shinohara O, Kato S. Growth and Endocrine Function in Long-term Adult Survivors of Childhood Stem Cell Transplant. Clin Pediatr Endocrinol. 2009;18(1):1-14. doi: 10.1297/cpe.18.1. Epub 2009 Feb 19. PMID: 24790374; PMCID: PMC4004878.
Copy Download .nbib Format: NLM
Bacteremia or pseudobacteremia? Review of pseudomonas fluorescens infections.

World journal of emergency medicine

Nishimura T, Hattori K, Inoue A, Ishii T, Yumoto T, Tsukahara K, Nakao A, Ishihara S, Nakayama S.
PMID: 28458762
World J Emerg Med. 2017;8(2):151-154. doi: 10.5847/wjem.j.1920-8642.2017.02.013.

No abstract available.

Cite
Nishimura T, Hattori K, Inoue A, et al. Bacteremia or pseudobacteremia? Review of pseudomonas fluorescens infections. World J Emerg Med. 2017;8(2):151-154doi: 10.5847/wjem.j.1920-8642.2017.02.013.
Nishimura, T., Hattori, K., Inoue, A., Ishii, T., Yumoto, T., Tsukahara, K., Nakao, A., Ishihara, S., & Nakayama, S. (2017). Bacteremia or pseudobacteremia? Review of pseudomonas fluorescens infections. World journal of emergency medicine, 8(2), 151-154. https://doi.org/10.5847/wjem.j.1920-8642.2017.02.013
Nishimura, Takeshi, et al. "Bacteremia or pseudobacteremia? Review of pseudomonas fluorescens infections." World journal of emergency medicine vol. 8,2 (2017): 151-154. doi: https://doi.org/10.5847/wjem.j.1920-8642.2017.02.013
Nishimura T, Hattori K, Inoue A, Ishii T, Yumoto T, Tsukahara K, Nakao A, Ishihara S, Nakayama S. Bacteremia or pseudobacteremia? Review of pseudomonas fluorescens infections. World J Emerg Med. 2017;8(2):151-154. doi: 10.5847/wjem.j.1920-8642.2017.02.013. PMID: 28458762; PMCID: PMC5409238.
Copy Download .nbib Format: NLM
Enhanced effect of fibroblast growth factor-2-containing dalteparin/protamine nanoparticles on hair growth.

Clinical, cosmetic and investigational dermatology

Takabayashi Y, Nambu M, Ishihara M, Kuwabara M, Fukuda K, Nakamura S, Hattori H, Kiyosawa T.
PMID: 27274299
Clin Cosmet Investig Dermatol. 2016 May 17;9:127-34. doi: 10.2147/CCID.S108187. eCollection 2016.

PURPOSE: Although treatments for alopecia are in high demand, not all treatments are safe and reliable. Dalteparin/protamine nanoparticles (D/P NPs) can effectively carry growth factors (GFs) such as fibroblast GF (FGF)-2. The purpose of this study was to identify...

Cite
Takabayashi Y, Nambu M, Ishihara M, et al. Enhanced effect of fibroblast growth factor-2-containing dalteparin/protamine nanoparticles on hair growth. Clin Cosmet Investig Dermatol. 2016;9:127-34doi: 10.2147/CCID.S108187.
Takabayashi, Y., Nambu, M., Ishihara, M., Kuwabara, M., Fukuda, K., Nakamura, S., Hattori, H., & Kiyosawa, T. (2016). Enhanced effect of fibroblast growth factor-2-containing dalteparin/protamine nanoparticles on hair growth. Clinical, cosmetic and investigational dermatology, 9127-34. https://doi.org/10.2147/CCID.S108187
Takabayashi, Yuki, et al. "Enhanced effect of fibroblast growth factor-2-containing dalteparin/protamine nanoparticles on hair growth." Clinical, cosmetic and investigational dermatology vol. 9 (2016): 127-34. doi: https://doi.org/10.2147/CCID.S108187
Takabayashi Y, Nambu M, Ishihara M, Kuwabara M, Fukuda K, Nakamura S, Hattori H, Kiyosawa T. Enhanced effect of fibroblast growth factor-2-containing dalteparin/protamine nanoparticles on hair growth. Clin Cosmet Investig Dermatol. 2016 May 17;9:127-34. doi: 10.2147/CCID.S108187. eCollection 2016. PMID: 27274299; PMCID: PMC4876681.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 512 entries